Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
combination drug
inhaler |
| gptkbp:activeIngredient |
gptkb:formoterol_fumarate
glycopyrrolate |
| gptkbp:approvalYear |
2016
|
| gptkbp:ATCCode |
R03AL05
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:drugClass |
long-acting beta2-adrenergic agonist
long-acting muscarinic antagonist |
| gptkbp:form |
pressurized metered-dose inhaler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bevespi Aerosphere
|
| gptkbp:indication |
chronic obstructive pulmonary disease
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:bfsParent |
gptkb:AstraZeneca_US
|
| gptkbp:bfsLayer |
6
|